Clinical Trial Update: Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Tarceva (erlotinib) with radiotherapy for locally advanced non-small cell lung cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Olfred Hansen | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-11-27